维普期刊资源整合服务平台（V6.5）

79篇 您的检索式：作者名="JL Porter"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Malignant pineal germ-cell tumors: an analysis of cases from three tumor registries 显示文摘	Villano JL Propp JM Porter KR	2008	Neuro Oncol2008，10，2：	1
2	The Boari bladder flap in lower ureteric in- juries显示文摘	Williams JL Porter RW	1966	Br J Urol1966，38，5：	1
3	The determinants of national innovative capacity显示文摘	FURMAN JL PORTER E STERN S		0，，：	1
4	Ameasure of perceived health in evaluationg general practice:the Nottingham Health rofile显示文摘	PORTER AM HOWIE JG	1991	Fam Pract1991，8，3：	1
5	Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder 显示文摘	Wright JL Porter ME Li CI	2006	Cancer2006，107，4：	1
6	Furthe studies on the anticancer activity of citrus limonoids显示文摘	Miller EG Porter JL BinnieWH	2004	Agric Food Chem2004，52，15：	1
7	Clinical presentation,histology,and treatment in 430 patients with primary tumors of the spinal cord,spinal meninges,or cauda equine显示文摘	Engelhard HH Villano JL Porter KR	2010	Neurosurg Spine2010，13，1：	1
8	Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder显示文摘	Wright JL Porter MP Li CI	2006	Cancer2006，107，3：	1
9	Ahemative approaches to the employee-organization relationship:Does investment in employees pay off显示文摘	Tsui A S Pearce JL Porter L W		0，，：	1
10	Differences in survival among patients with urachal and nonurachal adenocarcinomas of the blad- der显示文摘	Wright JL Porter MP Li CI	2006	Cancer2006，107，4：	1
11	The determinants of nationalinnovative capacity 显示文摘	Furman JL Porter ME Stem S	2002	Res Policy2002，31，6：	1
12	Clinical presen-tation, histology, and treatment in 430 patients with primarytumors of the spinal cord,spinal meninges, or cauda equina显示文摘	Engelhard HH Villano JL Porter KR	2010	J Neurosurg Spine2010，13，1：	1
13	Differences in survival amongpatients with urachal and nonurachal adenocarcinomas of thebladder显示文摘	Wright JL Porter MP Li Cl	2006	Cancer2006，107，4：	1
14	Polymeric proanathocyanidins 13C-NMR studies of procyanidins显示文摘	Porter JL Newman RH Foo LY	1982	J Chem Soc:Perkin I1982，，5：	1
15	The Determinants of National Innovative Capacity显示文摘	Furman JL Porter ME Stern S	2002	Research Policy2002，31，6：	1
16	Differences in survival among pa- tients with urachal and nonurachal adenocareinomas of the bladder 显示文摘	Wright JL Porter MP Li CI	2006	Cancer2006，107，4：	1
17	Laparoscopic partial nephrectomy: comparisonof transperitoneal and retroperitoneal approaches显示文摘	Wright JL Porter JR	2005	J Urol2005，174，3：	1
18	Human Spyl promotes survival of mammalian cells following DNA damage 显示文摘	Barnes EA Porter LA Lenormand JL	2003	Cancer Res2003，63，13：	1
19	Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis显示文摘	Wright JL Hotaling J Porter MP	2009	J Urol2009，181，3：	1
20	The Determinants of National Innovative Ca- pacity显示文摘	Furman JL Porter ME Stern S	2002	Research2002，2002，06：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示